Abstract
Purpose
The Carotid WALLSTENT (CWS) and Filter-Wire EZ (FWEZ) embolic protection devices for use in carotid arterial stenting (CAS) were newly approved for national health insurance coverage in Japan in April 2010. This article describes our initial experience of CAS using the CWS and FWEZ.
Material and methods
A group of 14 patients (12 men, 2 women; mean age 70.1 years, range 59–83 years) with 15 carotid artery stenoses at high risk for carotid endarterectomy were treated by CAS using the CWS and FWEZ. Of these stenoses, 5 were symptomatic with ≥50% stenosis of the common or internal carotid artery (ICA), and 10 were asymptomatic with ≥80% stenosis. The rates of technical success, ICA flow impairment during filter protection, periprocedural ischemic stroke, 30-day major adverse events (MAEs) (stroke, death, myocardial infarction), and development of new ischemic lesions on diffusion-weighted imaging (DWI) were assessed.
Results
CAS was successful in all cases. There was no ICA flow impairment, periprocedural ischemic stroke, or MAEs. DWI showed new ipsilateral ischemic lesions in only one patient (6.7%).
Conclusion
Our initial clinical experience using the CWS and FEWZ for CAS was generally excellent, and the incidence of postprocedural ischemic lesions was low.
Similar content being viewed by others
References
Sundt TM, Sandok BA, Whisnant JP. Carotid endarterectomy: complications and preoperative assessment of risk. Mayo Clin Proc 1975;50:301–306.
Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–1501.
White CJ, Iyer SS, Hopkins LN, Katzen BT, Russell ME. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 2006;67:503–512.
Ouriel K, Hertzer NR, Beven EG, O’Hara PJ, Krajewski LP, Clair DG, et al. Preprocedural risk stratification: identifying an appropriate population for carotid stenting. J Vasc Surg 2001;33:728–732.
Bates ER, Babb JD, Casey DE Jr, Cates CU, Duckwiler, GR, Feldman TE, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol 2007;49:126–170.
Iyer SS, White CJ, Hopkins LN, Katzen BT, Safian R, Wholey MH, et al. Carotid artery revascularization in high-surgicalrisk patients using the Carotid WALLSTENT and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group. J Am Coll Cardiol 2008;51:427–434.
Lin PH, Zhou W, Guerrero MA, McCoy SA, Felkai D, Kougias P, et al. Carotid artery stenting with distal protection using the Carotid WALLSTENT and filterwire neuroprotection: single-center experience of 380 cases with midterm outcomes. Vascular 2006;14:237–244.
Casserly IP, Abou-Chebl A, Fathi RB, Lee DS, Saw J, Exaire JE, et al. Slow-flow phenomenon during carotid artery intervention with embolic protection devices: predictors and clinical outcome. J Am Coll Cardiol 2005;46:1466–1472.
Takayama K, Nakagawa H, Iwasaki S, Taoka T, Miyasaka T, Myouchin K, et al. Initial experience of using the filter protection device during carotid artery stenting in Japan. Radiat Med 2008;26:348–354.
Siewiorek GM, Eskandari MK, Finol EA. The Angioguard embolic protection device. Expert Rev Med Devices 2008;5:287–296.
Sakamoto M, Taoka T, Nakagawa H, Takayama K, Wada T, Myouchin K, et al. Magnetic resonance plaque imaging to predict the occurrence of the slow-flow phenomenon in carotid artery stenting procedures. Neuroradiology 2009;20:20.
Kwon BJ, Han MH, Kang HS, Jung C. Protection filterrelated events in extracranial carotid artery stenting: a singlecenter experience. J Endovasc Ther 2006;13:711–722.
Jansen O, Fiehler J, Hartmann M, Bruckmann H. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE trial. Stroke 2009;40:841–846.
Bosiers M, de Donato G, Deloose K, Verbist J, Peeters P, Castriota F, et al. Does free cell area influence the outcome in carotid artery stenting? Eur J Vasc Endovasc Surg 2007;33:135–141; discussion 142–3.
Schillinger M, Gschwendtner M, Reimers B, Trenkler J, Stockx L, Mair J, et al. Does carotid stent cell design matter? Stroke 2008;39:90–99.
Du Mesnil de Rochemont R, Schneider S, Yan B, Lehr A, Sitzer M, Berkefeld J. Diffusion-weighted MR imaging lesions after filter-protected stenting of high-grade symptomatic carotid artery stenoses. AJNR Am J Neuroradiol 2006;27:1321–1325.
Kim SJ, Roh HG, Jeon P, Kim KH, Lee KH, Byun HS, et al. Cerebral ischemia detected with diffusion-weighted MR imaging after protected carotid artery stenting: comparison of distal balloon and filter device. Korean J Radiol 2007;8:276–285.
Kashiwagi J, Kiyosue H, Nakahara I, Matsumoto S, Hirohata M, Abe T, et al. Multicenter analysis of embolic complications during carotid artery stenting using Angioguard XP filter wire: predicting high risk patients by MR plaque image and length of stenosis. JNET 2008;2:179–187.
Siewiorek GM, Wholey MH, Finol EA. In vitro performance assessment of distal protection devices for carotid artery stenting: effect of physiological anatomy on vascular resistance. J Endovasc Ther 2007;14:712–724.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Takayama, K., Taoka, T., Nakagawa, H. et al. Initial experience of carotid artery stenting using the Carotid WALLSTENT and FilterWire EZ in Japan. Jpn J Radiol 29, 51–58 (2011). https://doi.org/10.1007/s11604-010-0518-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-010-0518-x